We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

Back to rankings

138 hedge funds and large institutions have $227M invested in DIPLOMAT PHARMACY, INC. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $536K

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

2% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 43

1% more funds holding

Funds holding: 137 → 138 (+1)

28% less capital invested

Capital invested by funds: $317M → $227M (-$90M)

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
44
Reduced
43
Closed
34
Calls
$2.56M
Puts
$536K
Net Calls
+$2.03M
Net Calls Change
-$946K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$11M
2
OAC
OMERS Administration Corp
Ontario, Canada
+$10.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.02M
4
OAM
Oxford Asset Management
United Kingdom
+$6.34M
5
SI
Stephens Inc
Arkansas
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$26.5M
2
Capital World Investors
Capital World Investors
California
-$17.1M
3
Capital International Investors
Capital International Investors
California
-$16.2M
4
DM
Deerfield Management
New York
-$14.7M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$1.8M -$4.67M -993,844 -69%
N
27
Nuveen
North Carolina
$1.78M +$771K +164,131 +58%
EGM
28
Engineers Gate Manager
New York
$1.73M +$1.32M +281,953 +188%
DCM
29
Dupont Capital Management
Delaware
$1.72M +$2.02M +429,300 New
Barclays
30
Barclays
United Kingdom
$1.7M +$1.72M +366,103 +631%
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
$1.47M -$3.51M -748,296 -67%
BFM
32
Boothbay Fund Management
New York
$1.28M +$560K +119,242 +59%
Ameriprise
33
Ameriprise
Minnesota
$1.17M -$44.6K -9,485 -3%
Morgan Stanley
34
Morgan Stanley
New York
$1.15M -$54.1K -11,523 -4%
SG Americas Securities
35
SG Americas Securities
New York
$1.01M +$1.18M +251,982 New
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$966K +$1.13M +241,423 New
WAM
37
Wolverine Asset Management
Illinois
$805K +$945K +201,255 New
EAM
38
Exane Asset Management
France
$800K +$939K +200,000 New
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$787K +$52.5K +11,181 +6%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$704K +$664K +141,391 +409%
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$682K +$544K +115,834 +212%
Group One Trading
42
Group One Trading
Illinois
$649K +$600K +127,695 +370%
WMSA
43
Weiss Multi-Strategy Advisers
New York
$637K +$747K +159,143 New
Walleye Capital
44
Walleye Capital
New York
$616K +$568K +120,921 +364%
Legal & General Group
45
Legal & General Group
United Kingdom
$589K +$44.7K +9,513 +7%
MSL
46
Mackay Shields LLC
New York
$587K +$690K +146,800 New
Two Sigma Investments
47
Two Sigma Investments
New York
$572K -$423K -89,977 -39%
Public Sector Pension Investment Board (PSP Investments)
48
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$515K -$76.1K -16,200 -11%
LI
49
Leap Investments
Illinois
$515K +$604K +128,626 New
Deutsche Bank
50
Deutsche Bank
Germany
$473K -$1.58M -335,561 -74%
1
2
3 4 5

DPLO Hedge Fund Activity: Q4 2019 in Review

138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2019, worth a combined $227M — down 28% from $317M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new DPLO positions and 34 closed out — a net gain of 1 holder — while 44 added to existing stakes and 43 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $11M. The largest seller was Armistice Capital, exiting entirely with an estimated $26.5M sold.

  • 138 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2019, up from 137 in Q3 2019.
  • Funds reported $227M of DIPLOMAT PHARMACY, INC. stock for Q4 2019, down 28% quarter-over-quarter.
  • 35 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2019 and 34 closed out, a net change of +1 holder.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2019 was Renaissance Technologies, an estimated $11M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2019 was Armistice Capital, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2019.